Map Pharmaceuticals
Get Full AccessDescription
- MAP Pharmaceuticals is dedicated to developing and commercializing new therapies for patients suffering from conditions that are not adequately treated by currently available medicines. The company is developing LEVADEX inhaled therapy for the potential treatment of migraine and has reported positive results from the efficacy portion of the first Phase 3 trial of LEVADEX. In addition, MAP Pharmaceuticals generates new pipeline opportunities by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history.
-
Headquarters:3964 Southview Dr , Richmond, Virginia, United States
More -
Phone Number: +1 650-386-3100
-
Website: https://www.mappharma.com
-
Employees:126
-
Revenue:$10 - 50M
-
Legal Name:Map Pharmaceuticals
-
Map Pharmaceuticals's Social Media
-
Is this data correct?
-
| NAICS Code: 325412 |
Show More
Frequently Asked Questions regarding Map Pharmaceuticals
-
Where are Map Pharmaceuticals's Headquarters?
Map Pharmaceuticals's Headquarters are in 3964 Southview Dr ,Richmond,Virginia,United States
-
What is Map Pharmaceuticals's phone number?
Map Pharmaceuticals's phone number is +1 650-386-3100
-
What is Map Pharmaceuticals's official website?
Map Pharmaceuticals's official website is https://www.mappharma.com
-
What is Map Pharmaceuticals's Revenue?
Map Pharmaceuticals's revenue is $10 - 50M
-
What is Map Pharmaceuticals's NAICS code?
Map Pharmaceuticals's NAICS code is 325412
-
How many employees are working in Map Pharmaceuticals
Map Pharmaceuticals has 126 employees
-
What is Map Pharmaceuticals's Industry?
Map Pharmaceuticals is in the industry of Pharmaceuticals
-
Who is Map Pharmaceuticals's Chief Medical Officer?
Map Pharmaceuticals's Chief Medical Officer is Stephen Shrewsbury

